OWINGS MILLS, MD – The Board of Certification/Accreditation (BOC) confirmed last week that CMS has reinstated BOC (effective Jan. 9, 2026) as a CMS-approved Accrediting Organization (AO) until further notice.

The reinstatement follows legal action taken by BOC in response to CMS’s abrupt termination of BOC’s approved AO status on Dec. 2, 2025. On Dec. 16, 2025, BOC filed a lawsuit, Board of Certification/Accreditation International, Inc. v. Robert F. Kennedy, Jr. et al, Case No. 1:25-cv-04150-MJM, in the U.S. District Court, District of Maryland.

At a hearing held Jan. 9, 2026, the Court granted BOC’s motion for a temporary restraining order (TRO) against CMS. As a result of the Court’s ruling, BOC is again authorized as a CMS-approved DMEPOS Accreditation Organization, and CMS has confirmed this status remains in effect until further notice.

What This Means for BOC-Accredited Facilities:

• Effective January 9, 2026, BOC can continue operations and is authorized to provide full accreditation- and reaccreditation-related services in 46 states.
• Effective January 9, 2026, BOC is authorized to accept new DMEPOS applications in 46 states.
• Restrictions announced in May 2025 continue to be in place for reaccreditation and new accreditation of suppliers in CA, FL, NY and TX.
• Suppliers with questions should contact BOC Compliance at [email protected] for individualized support and guidance to limit potential gaps in accreditation.

This matter is not related to and does not impact BOC’s certification programs. All BOC certification programs remain relevant and valid for the thousands of providers holding BOC credentials.

“We will continue to keep our customers informed and are grateful for their ongoing trust,” said Judi L. Knott, MA, MBA, CAE, president and CEO of BOC, a Medtrade exhibitor. “Our commitment to quality and to the professionals and businesses we serve remains steadfast, and we look forward to assisting with businesses’ accreditation needs.”